LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Do you take Victoza daily or weekly? Victoza (liraglutide) is administered once daily, not weekly—a crucial distinction for patients starting this GLP-1 receptor agonist for type 2 diabetes management. Unlike some newer formulations in the same drug class, Victoza's pharmacokinetic profile, with a half-life of approximately 13 hours, necessitates daily subcutaneous injection to maintain therapeutic blood levels. This article clarifies Victoza's dosing schedule, proper administration technique, weekly alternatives available in the UK, and guidance on managing missed doses to support optimal glycaemic control and treatment adherence.
Quick Answer: Victoza (liraglutide) is taken once daily by subcutaneous injection, not weekly.
Victoza (liraglutide) is administered once daily, not weekly. This is a crucial distinction that patients must understand when starting treatment. Liraglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class of medications, used primarily for managing type 2 diabetes mellitus and, in higher doses under a different brand name, for weight management.
The once-daily dosing schedule is determined by liraglutide's pharmacokinetic profile. After subcutaneous injection, the medication has a half-life of approximately 13 hours, which necessitates daily administration to maintain therapeutic blood levels. This differs significantly from some other GLP-1 receptor agonists that have been formulated for weekly administration.
Key points about Victoza's daily schedule:
The injection can be given at any time of day, with or without meals
It should ideally be administered at approximately the same time each day for consistency
Start with 0.6 mg once daily for at least one week to improve gastrointestinal tolerability; this initial dose is not intended for glycaemic control
After at least one week, increase to 1.2 mg daily; some patients may require 1.8 mg for optimal glycaemic control
Patients sometimes confuse Victoza with weekly GLP-1 receptor agonists due to marketing of newer formulations. However, according to the MHRA-approved product information, Victoza requires daily commitment. This daily regimen may suit some patients better than weekly injections, particularly those who prefer smaller, more frequent doses or who are establishing a new medication routine.
Importantly, Victoza is not a substitute for insulin and is not indicated for type 1 diabetes or diabetic ketoacidosis. When used with a sulfonylurea or insulin, dose reduction of these agents may be needed to reduce the risk of hypoglycaemia. Healthcare professionals should clearly explain the dosing frequency during prescribing consultations to prevent medication errors and ensure optimal adherence.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Proper administration technique is essential for ensuring Victoza's effectiveness and minimising injection site reactions. Victoza is supplied in a pre-filled, multi-dose pen device designed for subcutaneous injection, making it relatively straightforward for patients to self-administer at home.
Injection technique and site selection:
Victoza should be injected subcutaneously into the abdomen, thigh, or upper arm. Patients should rotate injection sites within the same region (for example, different areas of the abdomen) to reduce the risk of local skin reactions and lumps. The injection site should be clean and dry; follow the training provided by your healthcare professional regarding skin cleansing, and if using alcohol, allow it to dry completely before injecting.
The pen device allows patients to select their prescribed dose using a dial mechanism. Before each injection, patients should:
Always use a new needle for each injection
Prime the pen before first use according to the patient information leaflet
Check that the pen contains sufficient medication and that the solution appears clear and colourless
Never share pens with others, even if the needle is changed
After injection, remove the needle and dispose of it safely in a sharps container. Replace the pen cap to protect from light.
Timing and storage considerations:
While Victoza can be administered at any time of day, consistency is important. Taking it at the same time daily helps maintain stable blood levels and makes it easier to remember. The medication does not need to be taken with food, offering flexibility around mealtimes.
Unopened Victoza pens should be stored in a refrigerator (2°C to 8°C) and protected from light. Once in use, the pen can be stored at room temperature (below 30°C) or in the refrigerator for up to one month. Discard the pen 1 month after first use, even if some solution remains. The pen cap should be replaced after each use to protect from light. Patients should never freeze Victoza or use it if it has been frozen.
If you experience persistent injection site reactions, significant gastrointestinal symptoms, or have concerns about your technique, contact your GP or diabetes specialist nurse for guidance. Seek urgent medical advice if you develop severe, persistent abdominal pain (with or without vomiting), as this may indicate pancreatitis.
For patients who find daily injections burdensome or who struggle with adherence, several weekly GLP-1 receptor agonists are available as alternatives to Victoza. These medications work through similar mechanisms but have been formulated to provide therapeutic effects with once-weekly administration.
Available weekly GLP-1 receptor agonists in the UK include:
Trulicity (dulaglutide): Administered once weekly via a single-use pen device. NICE recommends dulaglutide as a treatment option for type 2 diabetes in specific circumstances outlined in guideline NG28.
Ozempic (semaglutide): A once-weekly injection that has shown superior glycaemic control and weight reduction compared to liraglutide in clinical trials. Semaglutide has a longer half-life (approximately one week), enabling weekly dosing.
These weekly alternatives offer effective glycaemic control, though individual responses vary. In clinical studies, semaglutide generally demonstrates greater HbA1c reductions and weight loss compared to liraglutide. The extended dosing interval may improve adherence for some patients, particularly those managing multiple daily medications or those with busy lifestyles.
Considerations when switching:
Switching from Victoza to a weekly alternative should only occur under medical supervision. Your healthcare provider will consider factors including your current glycaemic control, tolerability of liraglutide, injection preferences, and cost-effectiveness. There is no official direct equivalence between daily and weekly GLP-1 agonist doses, so your doctor will determine the appropriate starting dose of any alternative medication.
According to NICE guideline NG28, GLP-1 receptor agonists may be considered when triple therapy with metformin and two other oral drugs is not effective, not tolerated, or contraindicated, and for patients with specific weight or cardiovascular considerations.
The choice between daily and weekly GLP-1 receptor agonists is individualised. Some patients prefer the flexibility and smaller daily doses of Victoza, whilst others benefit from the convenience of weekly injections. Discuss your preferences and lifestyle factors with your diabetes care team to determine the most suitable option for your circumstances.
Missing a dose of Victoza occasionally is not uncommon, but understanding how to respond appropriately is important for maintaining glycaemic control and medication safety. The guidance for missed doses depends on when you remember and how much time has elapsed.
If you miss a dose:
According to the product information approved by the MHRA, if you forget your Victoza injection and it has been less than 12 hours since you would normally take it, you should administer the missed dose as soon as you remember. However, if more than 12 hours have passed, you should skip the missed dose entirely and resume your normal schedule with the next planned dose. Never take a double dose to compensate for a forgotten injection, as this increases the risk of adverse effects, particularly gastrointestinal symptoms such as nausea and vomiting.
Impact on blood glucose control:
Missing a single dose of Victoza is unlikely to cause immediate, severe hyperglycaemia in most patients, as the medication's effects persist for some time after administration. However, regular missed doses can lead to deteriorating glycaemic control, potentially resulting in elevated HbA1c levels over time. If you find yourself frequently forgetting doses, this may indicate that a weekly GLP-1 receptor agonist would be more suitable for your lifestyle.
If therapy has been interrupted for several days, you may experience increased gastrointestinal side effects when restarting. In this case, contact your diabetes team as re-titration from a lower dose may be necessary.
Strategies to improve adherence:
Set a daily alarm on your phone as a reminder
Link your injection to a consistent daily activity (such as breakfast or bedtime routine)
Use a medication diary or smartphone app to track doses
Keep your Victoza pen in a visible location (whilst maintaining appropriate storage conditions)
If you have missed multiple doses or are concerned about your blood glucose control, contact your GP or diabetes specialist nurse promptly. They can assess your glycaemic control, review your medication regimen, and discuss whether adjustments or alternative treatments might be beneficial.
Seek urgent medical advice if you develop severe, persistent abdominal pain (with or without vomiting), as this may indicate pancreatitis, a rare but serious side effect. You can report any suspected side effects to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
Yes, weekly alternatives such as Ozempic (semaglutide) or Trulicity (dulaglutide) are available, but switching should only occur under medical supervision. Your healthcare provider will determine the appropriate starting dose and assess suitability based on your glycaemic control, tolerability, and lifestyle factors.
If less than 12 hours have passed since your usual injection time, take the missed dose as soon as you remember. If more than 12 hours have elapsed, skip the missed dose and resume your normal schedule—never take a double dose to compensate.
Victoza (liraglutide) has a half-life of approximately 13 hours, requiring daily administration to maintain therapeutic blood levels. Weekly GLP-1 receptor agonists like semaglutide have longer half-lives (around one week), enabling once-weekly dosing through different pharmaceutical formulations.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
